not tagged
astrazeneca,novartis
['$azn', '$nvs']
$azn keeps up its complement defence at #eha23, but the oral contender danicopan is heading for a small niche and $nvs is coming with iptacopan. i spoke to the company for 
News Editor for Vantage covering biopharma and medtech; cat lover; banana run winner